ORKA
Oruka Therapeutics, Inc.
85.50$
-4.9%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 79.4% | 90.2% | 82.9% | 87.4% | 88.4% | 87.8% | 95.5% | 94.8% | 99.1% | 96.0% | 98.3% | 87.1% | 99.5% | 99.3% | 99.3% | 99.1% | 99.1% | 99.1% | 99.3% | 95.2% | 70.4% | |
| 35.0% | 32.7% | 26.6% | 69.9% | 82.8% | 86.1% | 91.4% | 90.9% | 98.1% | 95.2% | 98.0% | 30.0% | 70.4% | 96.8% | 98.0% | 97.3% | 97.2% | 98.5% | 98.9% | 15.5% | 9.6% | |
| 65.1% | 83.0% | 80.8% | 69.9% | 82.8% | 86.1% | 91.4% | 90.9% | 98.1% | 95.2% | 98.0% | 85.9% | 95.0% | 96.8% | 98.0% | 97.3% | 97.2% | 98.5% | 98.9% | 94.9% | 69.0% | |
| 1.1% | 4.6% | 0.5% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| 4.3% | 2.5% | 3.9% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| 47.5% | 62.1% | 43.9% | 148.0% | 20.9% | 17.0% | 11.8% | 9.5% | 8.8% | 8.6% | 3.8% | 9.9% | 16.9% | 11.6% | 10.8% | 7.7% | 7.1% | 3.3% | 2.2% | 3.5% | 3.4% | |
| 33.5% | 23.8% | 15.1% | 142.9% | 17.5% | 14.6% | 11.6% | 9.5% | 8.8% | 8.6% | 3.8% | 9.7% | 16.7% | 11.6% | 10.8% | 6.9% | 6.4% | 2.6% | 1.7% | 3.3% | 3.1% | |
| 7.7% | 2.0% | – | 111.0% | – | – | – | – | – | – | – | – | – | – | 0.3% | 0.1% | 0.2% | 0.2% | 0.2% | 0.1% | 0.1% | |
| 4.6% | 3.8% | 2.3% | 7.3% | 5.7% | 4.8% | 4.0% | 2.0% | 3.5% | – | – | – | 5.0% | 3.4% | 4.9% | 3.5% | 2.0% | 0.8% | – | 0.9% | 0.9% | |
| 52.5% | 37.9% | 56.1% | -48.0% | 79.1% | 83.0% | 88.2% | 90.5% | 91.2% | 91.4% | 96.2% | 90.1% | 83.1% | 88.4% | 89.2% | 92.3% | 92.9% | 96.7% | 97.8% | 96.5% | 96.6% | |
| -303.3% | -248.5% | -389.9% | -367.8% | -532.3% | -714.9% | -979.3% | -2,116.9% | -438.6% | -524.6% | -242.8% | -456.8% | -1,059.5% | -2,035.7% | -1,691.8% | -305.7% | -315.8% | -425.7% | -498.5% | -21.1% | -38.7% | |
| 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.1% | 0.1% | 0.2% | 0.4% | 0.9% | 1.3% | 9.3% | 25.3% | 33.4% | 38.1% | 4.2% | 9.3% |
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.